Not Yet RecruitingNot Applicable

Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)

80 participantsStarted 2025-01-01

Plain-language summary

Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic disorders which categorized according to the World Health Organization (WHO) into Philadelphia Chromosome positive (Ph +ve) including chronic myeloid leukemia (CML) and Philadelphia Chromosome negative (Ph -ve) like essential thrombocythemia (ET), polycythaemia vera (PV), and primary myelofibrosis (PMF) . the aim of the study is to Detection of leukocyte cell population data in patients with MPNs and Relation between leukocyte cell population and patients' clinical status.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with MPNs according to the recent WHO classification. Exclusion Criteria: * Patients with other types of myeloid neoplasms and/or not fulfil the WHO criteria for MPNs diagnosis.

What they're measuring

percentage of leukocyte cell in patients with MPNs

Timeframe: baseline

Trial details

NCT IDNCT06753279

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

Contact for this trial

Ola Gamal Taha Hussein, resident doctor

+201003196138 Ola.16266122@med.aun.edu.eg

View on ClinicalTrials.gov More Myeloproliferative Neoplasms (MPNs) trials